Proceedings of the fifth international RASopathies symposium: When development and cancer intersect

Area of Science:

• Genetics and Developmental Biology
• Oncology
• Molecular Biology

Background:

• RASopathies are developmental disorders caused by germline mutations in the RAS/mitogen-activated protein kinase (MAPK) pathway.
• These syndromes present overlapping features including craniofacial, cardiac, and neurological abnormalities, alongside an increased risk of cancer.
• The RAS pathway's known role in oncogenesis provides a link between developmental defects and cancer predisposition in RASopathies.

Framework:

• The fifth International RASopathies Symposium convened experts to discuss the intersection of development and cancer in these syndromes.
• Focus was placed on understanding the common pathogenetic etiology stemming from the RAS/MAPK pathway.
• The symposium explored how alterations in this crucial signaling pathway influence both normal development and the initiation of cancer.

Implementation:

• The symposium highlighted research on the diverse pathogenetic mechanisms leading to RAS/MAPK pathway dysregulation.
• Discussions covered the phenotypic spectrum of RASopathies, emphasizing shared abnormalities across different syndromes.
• Emphasis was placed on the clinical and molecular aspects of RASopathies, bridging developmental and oncological perspectives.

Implications:

• RASopathies serve as a valuable model for studying the dual impact of signaling pathway dysregulation in development and cancer.
• Understanding these syndromes can lead to improved diagnostic and therapeutic strategies for both rare genetic disorders and common cancers.
• Further research into the RAS/MAPK pathway in RASopathies may uncover fundamental mechanisms relevant to both developmental biology and cancer research.